Physician profile
John Everett Hubbard
NPI 1255310835
$980.82
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $76.26 · 2021: $200 · 2022: $64.22 · 2023: $165 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $286.28 | 2022-2024 | Invega, Invega Trinza, Spravato |
| Otsuka America Pharmaceutical, INC. | $134.64 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $134.54 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $129.16 | 2019 | |
| Neos Therapeutics, Lp | $105.06 | 2019-2021 | |
| Boston Scientific Corporation | $60.00 | 2024 | Spaceoar Vue System - 10ml |
| Alkermes, INC. | $57.83 | 2021-2022 | |
| Abbvie INC. | $34.23 | 2021 | |
| Tris Pharma INC | $21.76 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.